Evidence map›Paper›PMID 39803418›Full record

ReviewKidney medicine2025

Vascular Access for Home Hemodialysis: A Perspective on Tunneled Central Venous Catheters at Home.

Michael Alexander Aragon, Osama El Shamy, Sijie Zheng, Glenn M Chertow, Joel Glickman, Eric Weinhandl, Paul Komenda, Stephan Dunning, Frank Liu, Charmaine Lok

Abstract readReview
In one paragraph

Review in Kidney medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Michael Alexander AragonOutset Medical, San Jose, CA.
Osama El ShamyDivision of Renal Disease and Hypertension, Department of Medicine, George Washington University, Washington, DC.
Sijie ZhengDivision of Nephrology, The Permanente Medical Group, Kaiser Oakland Medical Center, Oakland, CA.
Glenn M ChertowDivision of Nephrology, Daprtment of Medicince, Stanford University, Palo Alto, CA.
Joel GlickmanSection on Renal Disease and Hypertension, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
Eric WeinhandlDaVita Clinical Research, Minneapolis, MN.
Paul KomendaDepartment of Medicine, Max Rady College of Medicine, University of Manitoba, WInnipeg, MB, Canada.
Stephan DunningOutset Medical, San Jose, CA.
Frank LiuDivision of Nephrology, Department of Medicine, Weill Cornell Medical College, New York, NY.
Charmaine LokFaculty of Medicine, University of Toronto, Toronto, ON, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Expansion of home hemodialysis (HHD) provides an opportunity to improve clinical outcomes, reduce cost of care, and address the staffing challenges currently faced in caring for patients with kidney failure on replacement therapy. To increase HHD expansion, current practices and barriers to home dialysis must be examined and addressed. One such barrier is vascular access for HHD; although tunneled hemodialysis central venous catheters (CVCs) have been used for decades, physicians still hesitate to send patients home without a mature, functional arteriovenous access. An expert panel of clinicians was convened by Outset Medical, a manufacturer of hemodialysis systems, to review the literature and generate consensus recommendations regarding the use of CVCs for HHD. Consistent with the most recent Kidney Disease Outcomes vascular access guidelines, the end-stage kidney disease life plan should be created via shared decision making for modality choices, with the corresponding dialysis access individualized for the patient, and for whom a CVC may represent the most appropriate vascular access to provide HHD.

Indexed as

arteriovenous fistulaarteriovenous graftAVFAVGcentral venous catheterCVCend stage kidney diseaseESKDHHDhome hemodialysisICHDincenter hemodialysisPDperitoneal dialysis

Identifiers

PMID39803418
PMCPMC11721530

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.